Skip to main content

Coagulative Disorders in HIV-Infected Patients

  • Chapter
  • 446 Accesses

Abstract

Coagulative disorders in human immunodeficiency virus (HIV)-infected patients can lead to two opposite conditions:

  1. 1.

    Thrombotic conditions;

  2. 2.

    Hemorrhagic conditions.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Koppel K, Bratt G, Schulman S, Bylund H, Sandstrom E (2002) Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy. J Acquir Immune Defic Syndr 29:441–449

    CAS  PubMed  Google Scholar 

  2. Hadigan C, Meigs JB, Rabe J et al (2001) Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab 86:939–943

    Article  CAS  PubMed  Google Scholar 

  3. Yki-Jarvinen H, Sutinen J, Silveira A et al (2003) Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. Arterioscler Thromb Vasc Biol 23:688–694

    Article  PubMed  CAS  Google Scholar 

  4. Drouet L, Scrobohaci ML, Janier M, Baudin B (1990) Endothelial cells: target for the HIV1 virus? Nouv Rev Fr Hematol 32:103–106

    CAS  PubMed  Google Scholar 

  5. Aukrust P, Bjornsen S, Lunden B et al (2000) Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy. Thromb Haemost 84:183–187

    CAS  Google Scholar 

  6. Wolf K, Tsakiris DA, Weber R, Erb P, Battegay M (2002) Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J Infect Dis 185:456–462

    Article  CAS  PubMed  Google Scholar 

  7. Miguez-Burbano MJ, Burbano X, Rodriguez A, Lecusay R, Rodriguez N, Shor-Posner G (2002) Development of thrombocytosis in HIV+ drug users: impact of antiretroviral therapy. Platelets 13:183–185

    Article  CAS  PubMed  Google Scholar 

  8. Saif MW, Greenberg B (2001) HIV and thrombosis: a review. AIDS Patient Care STDS 15:15–24

    Article  CAS  PubMed  Google Scholar 

  9. Sullivan PS, Dworkin MS, Jones JL, Hooper WC (2000) Epidemiology of thrombosis in HIVinfected individuals: The Adult/Adolescent Spectrum of HIV Disease Project. AIDS 14:321–324

    Article  CAS  PubMed  Google Scholar 

  10. Majluf-Cruz A, Silva-Estrada M, Sanchez-Barboza R et al (2004) Venous thrombosis among patients with AIDS. Clin Appl Thromb Hemost 10:19–25

    Article  PubMed  Google Scholar 

  11. Callens S, Florence E, Philippe M, Van Der PM, Colebunders R (2003) Mixed arterial and venous thromboembolism in a person with HIV infection. Scand J Infect Dis 35:907–908

    Article  PubMed  Google Scholar 

  12. Becker DM, Saunders TJ, Wispelwey B, Schain DC (1992) Case report: venous thromboembolism in AIDS. Am J Med Sci 303:395–397

    Article  CAS  PubMed  Google Scholar 

  13. Tanimowo M (1996) Deep vein thrombosis as a manifestation of the acquired immunodeficiency syndrome? A case report. Cent Afr J Med 42:327–328

    CAS  PubMed  Google Scholar 

  14. Vielhauer V, Schewe CK, Schlondorff D (1998) Bilateral thrombosis of the internal jugular veins with spasmodic torticollis in a patient with acquired immunodeficiency syndrome and disseminated cytomegalovirus infection. J Infect 37:90–91

    Article  CAS  PubMed  Google Scholar 

  15. Bayer DD, Sorbello AF, Condoluci DV (1995) Bilateral subclavian vein thrombosis in a patient with acquired immunodeficiency syndrome. J Am Osteopath Assoc 95:276–277

    CAS  PubMed  Google Scholar 

  16. Laing RB, Brettle RP, Leen CL (1996) Venous thrombosis in HIV infection. Int J STD AIDS 7:82–85

    Article  CAS  PubMed  Google Scholar 

  17. Meyohas MC, Roullet E, Rouzioux C et al (1989) Cerebral venous thrombosis and dual primary infection with human immunodeficiency virus and cytomegalovirus. J Neurol Neurosurg Psychiatry 52:1010–1011

    Article  CAS  PubMed  Google Scholar 

  18. Carr A, Brown D, Cooper DA (1997) Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. AIDS 11:1657–1658

    CAS  PubMed  Google Scholar 

  19. Narayanan TS, Narawane NM, Phadke AY, Abraham P (1998) Multiple abdominal venous thrombosis in HIV-seropositive patients. Indian J Gastroenterol 17:105–106

    CAS  PubMed  Google Scholar 

  20. Roberts SP, Haefs TM (1992) Central retinal vein occlusion in a middle-aged adult with HIV infection. Optom Vis Sci 69:567–569

    Article  CAS  PubMed  Google Scholar 

  21. Mansour AM, Li H, Segal EI (1996) Picture resembling hemicentral retinal vein occlusion in the acquired immunodeficiency syndrome: is it related to cytomegalovirus? Ophthalmologica 210:108–111

    CAS  PubMed  Google Scholar 

  22. Park KL, Marx JL, Lopez PF, Rao NA (1997) Noninfectious branch retinal vein occlusion in HIV-positive patients. Retina 17:162–164

    CAS  PubMed  Google Scholar 

  23. Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL (1993) Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood 81:1801–1807

    CAS  PubMed  Google Scholar 

  24. Bissuel F, Berruyer M, Causse X, Dechavanne M, Trepo C (1992) Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr 5:484–489

    CAS  PubMed  Google Scholar 

  25. Toulon P, Lamine M, Ledjev I et al (1993) Heparin cofactor II deficiency in patients infected with the human immunodeficiency virus. Thromb Haemost 70:730–735

    CAS  PubMed  Google Scholar 

  26. Muller MM, Griesmacher A (2000) Markers of endothelial dysfunction. Clin Chem Lab Med 38:77–85

    Article  CAS  PubMed  Google Scholar 

  27. Gujuluva C, Burns AR, Pushkarsky T et al (2001) HIV-1 penetrates coronary artery endothelial cells by transcytosis. Mol Med 7:169–176

    CAS  PubMed  Google Scholar 

  28. Madalosso C, de SN Jr, Ilstrup DM et al (1998) Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. Transplantation 66:294–297

    Article  CAS  PubMed  Google Scholar 

  29. Kaukoranta-Tolvanen SS, Ronni T, Leinonen M et al (1996) Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathog 21:407–411

    Article  CAS  PubMed  Google Scholar 

  30. Zhong DS, Lu XH, Conklin BS et al (2002) HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol 22:1560–1566

    Article  CAS  PubMed  Google Scholar 

  31. Stimmler MM, Quismorio FP Jr, McGehee WG et al (1989) Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 149:1833–1835

    Article  CAS  PubMed  Google Scholar 

  32. Karmochkine M, Raguin G (1998) Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir. AIDS 12:2499

    CAS  PubMed  Google Scholar 

  33. Ankri A, Bonmarchand M, Coutellier A, Herson S, Karmochkine M (1999) Antiphospholipid antibodies are an epiphenomenon in HIV-infected patients. AIDS 13:1282–1283

    Article  CAS  PubMed  Google Scholar 

  34. Feffer SE, Fox RL, Orsen MM et al (1995) Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South Med J 88:1126–1130

    CAS  PubMed  Google Scholar 

  35. Force L, Barrufet P, Herreras Z, Bolibar I (1999) Deep venous thrombosis and megestrol in patients with HIV infection. AIDS 13:1425–1426

    Article  CAS  PubMed  Google Scholar 

  36. Hirsh J, Hull RD, Raskob GE (1986) Epidemiology and pathogenesis of venous thrombosis. J Am Coll Cardiol 8(6 Suppl B):104B–113B

    Article  CAS  PubMed  Google Scholar 

  37. Kaufmann T, Nisce LZ, Metroka C (1991) Thromboembolism in AIDS-related Kaposi’s sarcoma. JAMA 266:2834

    Article  CAS  PubMed  Google Scholar 

  38. Heit JA (2002) Venous thromboembolism epidemiology: implications for prevention and management. Semin Thromb Hemost 28(Suppl 2):3–13

    Article  PubMed  Google Scholar 

  39. Biswas J, Roy CB, Krishna KS et al (2001) Detection of Mycobacterium tuberculosis by polymerase chain reaction in a case of orbital tuberculosis. Orbit 20:69–74

    Article  PubMed  Google Scholar 

  40. Friedman SM, Margo CE (1995) Bilateral central retinal vein occlusions in a patient with acquired immunodeficiency syndrome. Clinicopathologic correlation. Arch Ophthalmol 113:1184–1188

    CAS  Google Scholar 

  41. Iranzo A, Domingo P, Cadafalch J, Sambeat MA (1998) Intracranial venous and dural sinus thrombosis due to protein S deficiency in a patient with AIDS. J Neurol Neurosurg Psychiatry 64:688

    Article  CAS  PubMed  Google Scholar 

  42. Biswas J, Kumar AA, George AE et al (2000) Ocular and systemic lesions in children with HIV. Indian J Pediatr 67:721–724

    Article  CAS  PubMed  Google Scholar 

  43. Kleinschmidt-DeMasters BK, Mazowiecki M, Bonds LA et al (2000) Coccidioidomycosis meningitis with massive dural and cerebral venous thrombosis and tissue arthroconidia. Arch Pathol Lab Med 124:310–314

    CAS  PubMed  Google Scholar 

  44. Doberson MJ, Kleinschmidt-DeMasters BK (1994) Superior sagittal sinus thrombosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 118:844–846

    CAS  PubMed  Google Scholar 

  45. Abuaf N, Laperche S, Rajoely B et al (1997) Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 77:856–861

    CAS  PubMed  Google Scholar 

  46. Shahnaz S, Parikh G, Opran A (2004) Antiphospholipid antibody syndrome manifesting as a deep venous thrombosis and pulmonary embolism in a patient with HIV. Am J Med Sci 327:231–232

    Article  PubMed  Google Scholar 

  47. Ramos-Casals M, Cervera R, Lagrutta M et al (2004) Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 38:1009–1016

    Article  PubMed  Google Scholar 

  48. Sugerman RW, Church JA, Goldsmith JC, Ens GE (1996) Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J 15:106–111

    Article  CAS  PubMed  Google Scholar 

  49. Melchior JC, Messing B (1999) Home parenteral nutrition in acquired immunodeficiency syndrome patients. Nutrition 15:68–69

    Article  CAS  PubMed  Google Scholar 

  50. Duerksen DR, Ahmad A, Doweiko J et al (1996) Risk of symptomatic central venous thrombotic complications in AIDS patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 20:302–305

    Article  CAS  PubMed  Google Scholar 

  51. George SL, Swindells S, Knudson R, Stapleton JT (1999) Unexplained thrombosis in HIVinfected patients receiving protease inhibitors: report of seven cases. Am J Med 107:624–630

    Article  CAS  PubMed  Google Scholar 

  52. Wilde JT, Lee CA, Collins P et al (1999) Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disorders. Br J Haematol 107:556–559

    Article  CAS  PubMed  Google Scholar 

  53. Llibre JM, Romeu J, Lopez E, Sirera G (2002) Severe interaction between ritonavir and acenocoumarol. Ann Pharmacother 36:621–623

    Article  PubMed  Google Scholar 

  54. Rerolle JP, Canaud G, Fakhouri F et al (2004) Thrombotic microangiopathy and hypothermia in an HIV-positive patient: importance of cytomegalovirus infection. Scand J Infect Dis 36:234–237

    Article  PubMed  Google Scholar 

  55. Gervasoni C, Ridolfo AL, Vaccarezza M et al (2002) Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy. Clin Infect Dis 35:1534–1540

    Article  PubMed  Google Scholar 

  56. Gruszecki AC, Wehrli G, Ragland BD et al (2002) Management of a patient with HIV infectioninduced anemia and thrombocytopenia who presented with thrombotic thrombocytopenic purpura. Am J Hematol 69:228–231

    Article  PubMed  Google Scholar 

  57. Scaradavou A (2002) HIV-related thrombocytopenia. Blood Rev 16:73–76

    Article  CAS  PubMed  Google Scholar 

  58. Burbano X, Miguez MJ, Lecusay R et al (2001) Thrombocytopenia in HIV-infected drug users in the HAART era. Platelets 12:456–461

    Article  CAS  PubMed  Google Scholar 

  59. Carbonara S, Fiorentino G, Serio G et al (2001) Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors. J Infect 42:251–256

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Italia

About this chapter

Cite this chapter

Drouet, L. (2009). Coagulative Disorders in HIV-Infected Patients. In: Barbaro, G., Boccara, F. (eds) Cardiovascular Disease in AIDS. Springer, Milano. https://doi.org/10.1007/978-88-470-0761-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-0761-1_13

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0760-4

  • Online ISBN: 978-88-470-0761-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics